TFS
ABMD

Thoroughbred Financial Services’s Abiomed Inc ABMD Stock Holding History

Thoroughbred Financial Services’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,000
Closed -$260K – 252
2019
Q2 		$260K Sell
1,000
-138
-12% -$36.6K 0.1% 162
2019
Q1 		$325K Buy
1,138
+85
+8% +$28.3K 0.13% 166
2018
Q4 		$342K Buy
+1,053
New +$366K 0.17% 133

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Thoroughbred Financial Services's ABMD Position: Q3 2019 in Review

Thoroughbred Financial Services sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 1,000 shares — an estimated $260K sold.

Thoroughbred Financial Services first reported a position in ABMD in Q4 2018 and held it in 3 quarters. The position peaked at $342K in Q4 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Thoroughbred Financial Services reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Thoroughbred Financial Services sold 1,000 Abiomed Inc shares in Q3 2019, an estimated $260K.
  • Thoroughbred Financial Services first reported a position in Abiomed Inc in Q4 2018 and held it in 3 quarters.
  • Thoroughbred Financial Services's Abiomed Inc position peaked at $342K in Q4 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Thoroughbred Financial Services's 13F filing for Q3 2019, filed 12 Nov 2019.